FI891252A - 1,3,4,5-tetrahydrobenz /c,d/ indol. - Google Patents

1,3,4,5-tetrahydrobenz /c,d/ indol. Download PDF

Info

Publication number
FI891252A
FI891252A FI891252A FI891252A FI891252A FI 891252 A FI891252 A FI 891252A FI 891252 A FI891252 A FI 891252A FI 891252 A FI891252 A FI 891252A FI 891252 A FI891252 A FI 891252A
Authority
FI
Finland
Prior art keywords
tetrahydrobenz
indol
indoles
medicaments
amines
Prior art date
Application number
FI891252A
Other languages
English (en)
Other versions
FI891252A0 (fi
Inventor
Bodo Junge
Bernd Richter
Thomas Glaser
Joerg Traber
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI891252A0 publication Critical patent/FI891252A0/fi
Publication of FI891252A publication Critical patent/FI891252A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/90Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Detergent Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI891252A 1988-03-18 1989-03-16 1,3,4,5-tetrahydrobenz /c,d/ indol. FI891252A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3809155A DE3809155A1 (de) 1988-03-18 1988-03-18 1,3,4,5-tetrahydrobenz-(c,d)-indole

Publications (2)

Publication Number Publication Date
FI891252A0 FI891252A0 (fi) 1989-03-16
FI891252A true FI891252A (fi) 1989-09-19

Family

ID=6350115

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891252A FI891252A (fi) 1988-03-18 1989-03-16 1,3,4,5-tetrahydrobenz /c,d/ indol.

Country Status (18)

Country Link
US (1) US5021438A (fi)
EP (1) EP0332968B1 (fi)
JP (1) JPH02204479A (fi)
KR (1) KR890014474A (fi)
CN (1) CN1036566A (fi)
AT (1) ATE90093T1 (fi)
AU (1) AU614343B2 (fi)
DD (1) DD283606A5 (fi)
DE (2) DE3809155A1 (fi)
DK (1) DK131789A (fi)
ES (1) ES2058365T3 (fi)
FI (1) FI891252A (fi)
HU (1) HU204034B (fi)
IL (1) IL89623A (fi)
NO (1) NO890892L (fi)
NZ (1) NZ228341A (fi)
PT (1) PT90012B (fi)
ZA (1) ZA892049B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3826371A1 (de) * 1988-08-03 1990-02-08 Bayer Ag Tetrahydro-1-benz-(c,d)-indolpropionsaeure-sulfonamide
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
US5273975A (en) * 1989-06-09 1993-12-28 The Upjohn Company Heterocyclic amines having central nervous system activity
TW219933B (fi) * 1990-02-26 1994-02-01 Lilly Co Eli
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
US5212319A (en) * 1990-02-26 1993-05-18 Eli Lilly And Company Intermediates to 4-amino-hexahydrobenz[cd]indoles and processes therefor
DE69114210T2 (de) * 1990-08-13 1996-05-02 Hoechst Roussel Pharma Carbamoyl-1-(pyridinylalkyl)-1H-indole, -indoline und verwandte Verbindungen.
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
US5347013A (en) * 1991-03-28 1994-09-13 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
US5364856A (en) * 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US5656653A (en) * 1991-03-28 1997-08-12 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2A,3,4,5-hexahydrobenz[cd]indoles
US5244911A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
NZ260667A (en) * 1993-06-10 1997-05-26 Lilly Co Eli Preventing emesis or treating sexual dysfunction using tetrahydrobenz[cd]indole 6-carboxamides
TW430660B (en) * 1996-05-30 2001-04-21 Mochida Pharm Co Ltd Novel benzindole derivatives for neuron cell protection, processes for production, and the pharmaceutical compounds containing them
KR20030024799A (ko) * 2000-07-20 2003-03-26 뉴로젠 코포레이션 캡사이신 수용체 리간드
JP2022523774A (ja) 2019-02-27 2022-04-26 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 脳障害を治療するためのn-置換インドール及び他の複素環化合物
BR112021016620A2 (pt) 2019-02-27 2021-11-03 Univ California Azepino-indóis e outros heterociclos para o tratamento de distúrbios cerebrais
US20230295106A1 (en) * 2019-10-14 2023-09-21 The Regents Of The University Of California Ergoline-like compounds for promoting neural plasticity
CN115584206A (zh) * 2022-10-13 2023-01-10 吕辉 一种水性无机纳米陶瓷阻燃涂料及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE542760A (fi) * 1954-11-12
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4282240A (en) * 1979-11-23 1981-08-04 Merck & Co., Inc. Amino substituted tetrahydrobenzindoles
FR2471373A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux derives de la benzindolamine, leurs sels, procede de preparation, application a titre de medicaments et composition les renfermant
DE3346513A1 (de) 1983-12-22 1985-07-11 Süddeutsche Kühlerfabrik Julius Fr. Behr GmbH & Co. KG, 7000 Stuttgart Vorrichtung zum erwaermen von wasser
DE3346573A1 (de) * 1983-12-23 1985-07-04 Troponwerke GmbH & Co KG, 5000 Köln 1,3,4,5-tetrahydrobenz(c,d)indole, ein verfahren zu ihrer herstellung und ihre verwendung
IL74222A (en) * 1984-02-06 1988-07-31 Lilly Co Eli 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
US4683313A (en) * 1985-06-24 1987-07-28 Eli Lilly And Company 2-alkyl(or phenyl)thio-6-N alkyl ergolines and 4-dialkylaminotetrahydrobenz[c,d]indoles
DE3719924A1 (de) * 1986-12-22 1988-06-30 Bayer Ag 8-substituierte 2-aminotetraline
DE3718892A1 (de) * 1987-06-05 1988-12-22 Bayer Ag Polyhydrobenz(c,d)indol-sulfonamide

Also Published As

Publication number Publication date
AU3152689A (en) 1989-09-28
FI891252A0 (fi) 1989-03-16
DK131789D0 (da) 1989-03-17
PT90012B (pt) 1994-06-30
PT90012A (pt) 1989-11-10
NO890892L (no) 1989-09-19
DE58904539D1 (de) 1993-07-08
AU614343B2 (en) 1991-08-29
NZ228341A (en) 1990-12-21
IL89623A (en) 1993-01-14
DD283606A5 (de) 1990-10-17
EP0332968B1 (de) 1993-06-02
HUT50767A (en) 1990-03-28
US5021438A (en) 1991-06-04
ES2058365T3 (es) 1994-11-01
CN1036566A (zh) 1989-10-25
ATE90093T1 (de) 1993-06-15
DK131789A (da) 1989-09-19
NO890892D0 (no) 1989-03-02
HU204034B (en) 1991-11-28
ZA892049B (en) 1989-11-29
IL89623A0 (en) 1989-09-10
KR890014474A (ko) 1989-10-23
DE3809155A1 (de) 1989-09-28
JPH02204479A (ja) 1990-08-14
EP0332968A1 (de) 1989-09-20

Similar Documents

Publication Publication Date Title
FI891252A0 (fi) 1,3,4,5-tetrahydrobenz /c,d/ indol.
IT8548435A0 (it) Derivato di indolo,composizione farmaceutica che lo contiene e procedimento per prepararlo
MY109880A (en) Substituted biphenylpyridones
ATE109002T1 (de) Wasserlösliche antineoplastische taxolderivate.
LU91758I2 (fr) Denosumab et ses dérivés pharmaceutiquement acceptables (PROLIA®)
DK183386A (da) Sucralfatsuspension
IT8219730A0 (it) Derivati 5-amminometil-ossazolidinici, procedimento per la loro preparazione, e loro applicazione in terapia.
BR9306201A (pt) Derivados de indol como agonistas 5-ht1
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
BR9100767A (pt) Composto,formulacao farmaceutica e metodo para a preparacao de hipurato de 4-(di-n-propil)amino-1,3,4,5-tetrahidrobenz(cd)indol cristalino
ATE99310T1 (de) Substituierte 1,8-naphthyridine.
DE69719563D1 (de) Pharmazeutische wirksame trizyklische amine
DE69003935D1 (de) Herstellung eines N-substituierten Phenylendiamins.
DK581183A (da) 2-azabicyclo(2.2.1)heptan-derivater, fremgangsmaader til deres fremstilling, midler indeholdende disse derivater og deres anvendelse, samt 2-azabicyclo(2.2.1)heptan-derivater som mellemprodukter samt fremgangsmaader til deres fremstilling
DK590984D0 (da) Pyrrolo(3,2,1-hi)indol-derivater, fremgangsmaade til fremstilling deraf samt anvendelse af saadanne forbindelser som laegemidler
IT1227852B (it) Procedimento per preparare derivati della 1,5 benzotiazepina.
NO911810D0 (no) Pyrrolo(2,3-b)indol-ketoner og analoger, fremgangsmaate for fremstilling og anvendelse som medikamenter.
ATE92317T1 (de) Verwendung von pyrrol(3,2,1-hi>indol-derivaten zur herstellung eines arzneimittels zur behandlung von diabetes.
YU32691A (sh) 6-supstituisani-heksahidrobenz c,d indoli i postupak za njegovo dobijanje
IT1207805B (it) Procedimento per preparare coniugati di metalloproteine e nuovi derivati dei coniugati stessi.
IT8919648A0 (it) Derivati dell'indolo, procedimento per la loro preparazione e mezzi farmaceutici contenenti tali composti.
NO923592L (no) Polyhydroksycyklopentanderivat og fremgangsmaate til fremstilling derav, samt mikroorganisme som er anvendelig i fremgangsmaaten
IT8719026A0 (it) Procedimento per preparare derivati alcossi alchiliden, idrazino, piridazinici.
IT8863261V0 (it) Contenitore per uova, perfezionato.
NO884306D0 (no) Fremgangsmaate til fremstilling av animalsk ferdigfor for pattedyr og ferdigfor fremstilt i overensstemmelse med fremgangsmaaten.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT